Article
Molecular forms of PSA: What does the future hold?
Among urologic tumor markers, the discovery and application of prostate-specific antigen has established PSA as a vital tool for the early diagnosis, staging, and monitoring of men with prostate cancer.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Related Videos
Anne Schuckman, MD, outlines current challenges in NMIBC care
Managing Abiraterone Intolerance: Alternative Dosing Strategies in Practice
Decision-Making and Multidisciplinary Counseling for Nodal Involvement on PSMA PET
Justin Dubin, MD, on the use of AI in the male infertility space
Bilal Chughtai, MD, discusses pivotal trial of the Butterfly device for BPH
Investigators compare trimodal therapy vs cystectomy in MIBC
Rethinking First-Line Treatments: Will BCG Continue to Be the Standard in NMIBC?
In the Pipeline: Novel Treatment Delivery Methods for NMIBC
Investigators assess ctDNA’s role in NMIBC
RX Review: Implementing mitomycin for LG-IR-NMIBC in clinical practice
Related Content
